Theravance Biopharma Inc (TBPH)

Capital Lease Obligations

$38.57M

Quarterly · Period ending: · USD

TBPH logo

TBPH Capital Lease Obligations

Latest reported$38.57M
TBPH Quarterly Capital Lease Obligations ($0.00 → $38.57M)
High-resolution chart · PNG

TBPH capital lease obligations history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Theravance Biopharma Inc Capital Lease Obligations — Quarterly (USD)
Period endingCapital Lease Obligations (USD)
38,569,000
29,752,000
31,758,000
44,595,000
46,457,000
48,156,000
49,820,000
44,981,000
46,660,000
47,903,000
49,159,000
50,831,000
51,681,000
51,194,000
52,160,000
52,073,000
50,642,000
51,469,000
52,681,000
55,369,000
57,768,000
58,246,000
47,220,000
47,823,000
47,631,000
47,199,000
47,725,000
55,453,000
56,452,000
48,493,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.